Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
5.76
-0.10 (-1.71%)
Nov 18, 2026, 3:00 PM CST
SHA:600613 Revenue
Shanghai Shenqi Pharmaceutical Investment Management had revenue of 401.31M CNY in the quarter ending September 30, 2026, a decrease of -8.17%. This brings the company's total for the last twelve months to 1.80B, down -4.22% year-over-year. In the year 2025, Shanghai Shenqi Pharmaceutical Investment Management had annual revenue of 1.95B, down -4.71%. That makes Shanghai Shenqi Pharmaceutical Investment Management the 15,307th largest company in the world by revenue and 2,755th in China.
Revenue (ttm)
1.80B
Revenue Growth
-4.22%
P/S Ratio
1.64
Revenue / Employee
1.51M
Employees
1,196
Market Cap
2.90B
Revenue by Segment
- Pharmaceutical Manufacturing 1.12B 57.5%
- Pharmaceutical Business 829.28M 42.5%
Fiscal year ended Dec 31, 2025 See the full SHA:600613 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.95B | -96.44M | -4.71% |
| Dec 31, 2024 | 2.05B | -292.14M | -12.48% |
| Dec 31, 2023 | 2.34B | -47.67M | -2.00% |
| Dec 31, 2022 | 2.39B | 85.58M | 3.72% |
| Dec 31, 2021 | 2.30B | 484.03M | 26.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Int'l Group | 34.69B |
| Zhejiang Zhenyuan Share | 1.79B |
| GuangYuYuan Chinese Herbal Medicine | 1.31B |
| Hangzhou Minsheng Healthcare | 902.62M |
| Hubei Guangji Pharmaceutical | 630.16M |
| Hangzhou Bio-Sincerity Pharma-Tech | 617.95M |
| Aurora Optoelectronics | 604.05M |
| Shandong Keyuan Pharmaceutical | 578.07M |